Copyright Reports & Markets. All rights reserved.

Global Total Intravenous Anesthesia (TIVA) Market Research Report 2021

Request for Sample of this report
Buy now

1 Total Intravenous Anesthesia (TIVA) Market Overview

  • 1.1 Product Overview and Scope of Total Intravenous Anesthesia (TIVA)
  • 1.2 Total Intravenous Anesthesia (TIVA) Segment by Type
    • 1.2.1 Global Total Intravenous Anesthesia (TIVA) Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Propofol
    • 1.2.3 Etomidate
    • 1.2.4 Midazolam
    • 1.2.5 Barbiturates
    • 1.2.6 Others
  • 1.3 Total Intravenous Anesthesia (TIVA) Segment by Application
    • 1.3.1 Global Total Intravenous Anesthesia (TIVA) Sales Comparison by Application: (2021-2027)
    • 1.3.2 Predominantly Emergency
    • 1.3.3 Orthopedic
    • 1.3.4 Cosmetic Surgeries
    • 1.3.5 Others
  • 1.4 Global Total Intravenous Anesthesia (TIVA) Market Size Estimates and Forecasts
    • 1.4.1 Global Total Intravenous Anesthesia (TIVA) Revenue 2016-2027
    • 1.4.2 Global Total Intravenous Anesthesia (TIVA) Sales 2016-2027
    • 1.4.3 Total Intravenous Anesthesia (TIVA) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Total Intravenous Anesthesia (TIVA) Market Competition by Manufacturers

  • 2.1 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Total Intravenous Anesthesia (TIVA) Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Total Intravenous Anesthesia (TIVA) Manufacturing Sites, Area Served, Product Type
  • 2.5 Total Intravenous Anesthesia (TIVA) Market Competitive Situation and Trends
    • 2.5.1 Total Intravenous Anesthesia (TIVA) Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Total Intravenous Anesthesia (TIVA) Players Market Share by Revenue
    • 2.5.3 Global Total Intravenous Anesthesia (TIVA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Total Intravenous Anesthesia (TIVA) Retrospective Market Scenario by Region

  • 3.1 Global Total Intravenous Anesthesia (TIVA) Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Total Intravenous Anesthesia (TIVA) Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Total Intravenous Anesthesia (TIVA) Market Facts & Figures by Country
    • 3.3.1 North America Total Intravenous Anesthesia (TIVA) Sales by Country
    • 3.3.2 North America Total Intravenous Anesthesia (TIVA) Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Total Intravenous Anesthesia (TIVA) Market Facts & Figures by Country
    • 3.4.1 Europe Total Intravenous Anesthesia (TIVA) Sales by Country
    • 3.4.2 Europe Total Intravenous Anesthesia (TIVA) Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Total Intravenous Anesthesia (TIVA) Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Total Intravenous Anesthesia (TIVA) Sales by Region
    • 3.5.2 Asia Pacific Total Intravenous Anesthesia (TIVA) Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Total Intravenous Anesthesia (TIVA) Market Facts & Figures by Country
    • 3.6.1 Latin America Total Intravenous Anesthesia (TIVA) Sales by Country
    • 3.6.2 Latin America Total Intravenous Anesthesia (TIVA) Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Total Intravenous Anesthesia (TIVA) Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Total Intravenous Anesthesia (TIVA) Sales by Country
    • 3.7.2 Middle East and Africa Total Intravenous Anesthesia (TIVA) Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Total Intravenous Anesthesia (TIVA) Historic Market Analysis by Type

  • 4.1 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2016-2021)
  • 4.2 Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Type (2016-2021)
  • 4.3 Global Total Intravenous Anesthesia (TIVA) Price by Type (2016-2021)

5 Global Total Intravenous Anesthesia (TIVA) Historic Market Analysis by Application

  • 5.1 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2016-2021)
  • 5.2 Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Application (2016-2021)
  • 5.3 Global Total Intravenous Anesthesia (TIVA) Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 B. Braun Medical
    • 6.1.1 B. Braun Medical Corporation Information
    • 6.1.2 B. Braun Medical Description and Business Overview
    • 6.1.3 B. Braun Medical Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 B. Braun Medical Total Intravenous Anesthesia (TIVA) Product Portfolio
    • 6.1.5 B. Braun Medical Recent Developments/Updates
  • 6.2 Astrazeneca
    • 6.2.1 Astrazeneca Corporation Information
    • 6.2.2 Astrazeneca Description and Business Overview
    • 6.2.3 Astrazeneca Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Astrazeneca Total Intravenous Anesthesia (TIVA) Product Portfolio
    • 6.2.5 Astrazeneca Recent Developments/Updates
  • 6.3 Fresenius-Kabi
    • 6.3.1 Fresenius-Kabi Corporation Information
    • 6.3.2 Fresenius-Kabi Description and Business Overview
    • 6.3.3 Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Product Portfolio
    • 6.3.5 Fresenius-Kabi Recent Developments/Updates
  • 6.4 AbbVie
    • 6.4.1 AbbVie Corporation Information
    • 6.4.2 AbbVie Description and Business Overview
    • 6.4.3 AbbVie Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 AbbVie Total Intravenous Anesthesia (TIVA) Product Portfolio
    • 6.4.5 AbbVie Recent Developments/Updates
  • 6.5 Baxter Healthcare
    • 6.5.1 Baxter Healthcare Corporation Information
    • 6.5.2 Baxter Healthcare Description and Business Overview
    • 6.5.3 Baxter Healthcare Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Baxter Healthcare Total Intravenous Anesthesia (TIVA) Product Portfolio
    • 6.5.5 Baxter Healthcare Recent Developments/Updates
  • 6.6 Maruishi
    • 6.6.1 Maruishi Corporation Information
    • 6.6.2 Maruishi Description and Business Overview
    • 6.6.3 Maruishi Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Maruishi Total Intravenous Anesthesia (TIVA) Product Portfolio
    • 6.6.5 Maruishi Recent Developments/Updates
  • 6.7 Piramal
    • 6.6.1 Piramal Corporation Information
    • 6.6.2 Piramal Description and Business Overview
    • 6.6.3 Piramal Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Piramal Total Intravenous Anesthesia (TIVA) Product Portfolio
    • 6.7.5 Piramal Recent Developments/Updates
  • 6.8 Hikma Pharmaceuticals
    • 6.8.1 Hikma Pharmaceuticals Corporation Information
    • 6.8.2 Hikma Pharmaceuticals Description and Business Overview
    • 6.8.3 Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Product Portfolio
    • 6.8.5 Hikma Pharmaceuticals Recent Developments/Updates
  • 6.9 Mylan
    • 6.9.1 Mylan Corporation Information
    • 6.9.2 Mylan Description and Business Overview
    • 6.9.3 Mylan Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Mylan Total Intravenous Anesthesia (TIVA) Product Portfolio
    • 6.9.5 Mylan Recent Developments/Updates
  • 6.10 Nhwa
    • 6.10.1 Nhwa Corporation Information
    • 6.10.2 Nhwa Description and Business Overview
    • 6.10.3 Nhwa Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Nhwa Total Intravenous Anesthesia (TIVA) Product Portfolio
    • 6.10.5 Nhwa Recent Developments/Updates
  • 6.11 Hengrui
    • 6.11.1 Hengrui Corporation Information
    • 6.11.2 Hengrui Total Intravenous Anesthesia (TIVA) Description and Business Overview
    • 6.11.3 Hengrui Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Hengrui Total Intravenous Anesthesia (TIVA) Product Portfolio
    • 6.11.5 Hengrui Recent Developments/Updates
  • 6.12 Lunan
    • 6.12.1 Lunan Corporation Information
    • 6.12.2 Lunan Total Intravenous Anesthesia (TIVA) Description and Business Overview
    • 6.12.3 Lunan Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Lunan Total Intravenous Anesthesia (TIVA) Product Portfolio
    • 6.12.5 Lunan Recent Developments/Updates

7 Total Intravenous Anesthesia (TIVA) Manufacturing Cost Analysis

  • 7.1 Total Intravenous Anesthesia (TIVA) Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Total Intravenous Anesthesia (TIVA)
  • 7.4 Total Intravenous Anesthesia (TIVA) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Total Intravenous Anesthesia (TIVA) Distributors List
  • 8.3 Total Intravenous Anesthesia (TIVA) Customers

9 Total Intravenous Anesthesia (TIVA) Market Dynamics

  • 9.1 Total Intravenous Anesthesia (TIVA) Industry Trends
  • 9.2 Total Intravenous Anesthesia (TIVA) Growth Drivers
  • 9.3 Total Intravenous Anesthesia (TIVA) Market Challenges
  • 9.4 Total Intravenous Anesthesia (TIVA) Market Restraints

10 Global Market Forecast

  • 10.1 Total Intravenous Anesthesia (TIVA) Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Total Intravenous Anesthesia (TIVA) by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Total Intravenous Anesthesia (TIVA) by Type (2022-2027)
  • 10.2 Total Intravenous Anesthesia (TIVA) Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Total Intravenous Anesthesia (TIVA) by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Total Intravenous Anesthesia (TIVA) by Application (2022-2027)
  • 10.3 Total Intravenous Anesthesia (TIVA) Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Total Intravenous Anesthesia (TIVA) by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Total Intravenous Anesthesia (TIVA) by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Propofol
    Etomidate
    Midazolam
    Barbiturates
    Others

    Segment by Application
    Predominantly Emergency
    Orthopedic
    Cosmetic Surgeries
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    B. Braun Medical
    Astrazeneca
    Fresenius-Kabi
    AbbVie
    Baxter Healthcare
    Maruishi
    Piramal
    Hikma Pharmaceuticals
    Mylan
    Nhwa
    Hengrui
    Lunan

    Buy now